| Literature DB >> 28743719 |
Annalisa Del Prete1,2, Laura Martínez-Muñoz3, Cristina Mazzon2, Lara Toffali4, Francesca Sozio1,2, Lorena Za5, Daniela Bosisio1, Luisa Gazzurelli1, Valentina Salvi1, Laura Tiberio1, Chiara Liberati5, Eugenio Scanziani6, Annunciata Vecchi2, Carlo Laudanna4, Mario Mellado3, Alberto Mantovani2,7,8, Silvano Sozzani1,2.
Abstract
CCRL2 is a 7-transmembrane domain receptor that shares structural and functional similarities with the family of atypical chemokine receptors (ACKRs). CCRL2 is upregulated by inflammatory signals and, unlike other ACKRs, it is not a chemoattractant-scavenging receptor, does not activate β-arrestins, and is widely expressed by many leukocyte subsets. Therefore, the biological role of CCRL2 in immunity is still unclear. We report that CCRL2-deficient mice have a defect in neutrophil recruitment and are protected in 2 models of inflammatory arthritis. In vitro, CCRL2 was found to constitutively form homodimers and heterodimers with CXCR2, a main neutrophil chemotactic receptor. By heterodimerization, CCRL2 could regulate membrane expression and promote CXCR2 functions, including the activation of β2-integrins. Therefore, upregulation of CCRL2 observed under inflammatory conditions is functional to finely tune CXCR2-mediated neutrophil recruitment at sites of inflammation.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28743719 DOI: 10.1182/blood-2017-04-777680
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113